Annual Report 2017 | Page 5

UH CANCER CENTER CLINICAL TRIALS SHADOWING PROGRAM

JANA WIELAND

UH CANCER CENTER CLINICAL TRIALS SHADOWING PROGRAM

As a cancer survivor , I had the unique experience of witnessing the medical profession from the perspective of a patient . I saw that my local oncologist not only possessed expertise in his feld , but also knew how to address my overall well-being . It is this combination of scientifc expertise , deep empathy , dedication and professionalism that I want to emulate throughout my medical career .
I AM ETERNALLY GRATEFUL FOR THE MORE THAN 200 PEDIATRIC PATIENTS THAT ENROLLED IN A CLINICAL TRIAL THAT ENABLED ME TO RECEIVE A LESS TOXIC CHEMOTHERAPY REGIMEN .” - JANA WIELAND
Since September 2017 , I have been engaged in the Clinical Trials Shadowing Program at the UH Cancer Center as a frst-year John A . Burns School of Medicine student . I was excited to learn more about the clinical trial process and the regulatory side of cancer protocols . Throughout my frst rotation at the UH Cancer Center , I learned about the investigator-initiated clinical trial process as well as the regulatory side of initiating and integrating clinical trials . I look forward to the next unit at Tripler Army Medical Center , where I will shadow an oncologist to directly see patients participating in trials .
My experiences with undergraduate research and the UH Cancer Center program have cemented my passion for scientifc investigation . It is a very rewarding feeling to know that my small contribution to cancer research could have an impact on the lives of individuals affected by cancer . I have the opportunity to engage with many research active physicians , and I hope to follow in their footsteps by leaving my own mark on translational research .
Clinical Trials Shadowing Program
• Year-long community health elective for frst-year medical students at the John A . Burns School of Medicine
• Opportunity to learn from UH Cancer Center National Cancer Institute ’ s Community Oncology Research Program physicians who are conducting clinical trials
3